Multi-Agent LLM Systems for Clinical Interpretation: Governance for Singapore Hospitals

Multi-Agent LLM Systems for Clinical Interpretation: Governance for Singapore Hospitals

Multi-agent large language model (LLM) architectures are moving from research prototypes to clinical deployment candidates. A recent preprint describes a system that interprets health checkup results by routing user queries to specialized agents—one for longitudinal reasoning, another for lifestyle guidance, a third for healthcare navigation—then synthesizing their outputs into personalized recommendations [4]. The architecture is elegant: identify multiple intents, map each to a task-specific agent, execute in parallel, merge results. But when we evaluate these systems for deployment in Singapore hospitals, we find a governance gap that existing frameworks do not address: how do you validate, monitor, and audit a system where clinical reasoning is distributed across multiple LLM agents, each with its own prompt, retrieval context, and failure mode?

This post is for hospital CIOs, clinical informatics teams, and AI governance leads in Singapore who need to evaluate multi-agent LLM proposals for clinical decision support, patient communication, or care coordination. We walk through the specific governance challenges these architectures introduce, map them to Singapore's Model AI Governance Framework [1] and WHO AI health guidance [2], and propose a five-checkpoint validation protocol.

Key takeaways

• Multi-agent LLM systems distribute clinical reasoning across specialized agents, each with distinct prompts, retrieval contexts, and failure modes—creating new governance surfaces that single-agent frameworks do not cover.
• Singapore's Model AI Governance Framework [1] emphasizes explainability and human oversight, but does not specify how to audit intent routing, agent handoff logic, or cross-agent output synthesis in multi-agent architectures.
• WHO guidance [2] requires traceability and accountability, which demands agent-level logging, version control for each agent's prompt and retrieval pipeline, and clear escalation paths when agents disagree.
• A five-checkpoint validation protocol—intent classification accuracy, agent output consistency, synthesis logic transparency, failure mode mapping, and cross-agent audit trails—provides a practical governance scaffold for Singapore hospitals evaluating multi-agent clinical LLMs.
• Operational deployment requires monitoring at the agent level, not just the system level: track which agents are invoked, how often they disagree, and where synthesis logic overrides individual agent outputs.

Why multi-agent architectures complicate clinical AI governance

Single-agent LLM systems—where one model processes a query, retrieves context, and generates a response—are challenging enough to govern. We have written about RAG evaluation for clinical document retrieval and the need for version-aware pipelines. Multi-agent systems add three new governance surfaces:

Intent routing errors. The system must classify user intent and route queries to the correct agent. A misclassification—sending a medication interaction question to the lifestyle guidance agent instead of the clinical reasoning agent—can produce plausible but incorrect advice. Unlike retrieval errors, which leave traces in the context window, intent routing failures are often invisible in the final output.

Agent handoff ambiguity. When a query spans multiple intents (e.g., "Should I adjust my diabetes medication given my recent HbA1c and my plan to start exercising?"), the system must decide which agents to invoke and how to sequence or parallelize them. The preprint describes parallel execution with output synthesis [4], but does not specify how conflicts are resolved when agents produce contradictory recommendations.

Synthesis opacity. The final output is not the direct product of any single agent, but a synthesized summary. If the synthesis step is itself an LLM call ("Given these three agent outputs, write a coherent response"), we have introduced a fourth agent with its own failure modes. If synthesis is rule-based, those rules become a critical governance artifact that must be versioned, tested, and audited.

These surfaces are not hypothetical. We have reviewed multi-agent proposals for patient triage, care coordination, and chronic disease management in Singapore health systems. In every case, the vendor's validation focused on end-to-end accuracy ("Does the final output match clinician judgment?") without auditing the intermediate steps. When we asked for agent-level logs—which agent was invoked, what context it retrieved, what it recommended before synthesis—the systems did not capture that data.

How Singapore's governance frameworks apply (and where they fall short)

Singapore's Model AI Governance Framework [1] provides principles for transparency, explainability, and human oversight. It emphasizes that AI systems should be "explainable to the extent required by stakeholders" and that "decisions made by AI systems should be subject to human review." These principles map cleanly to single-agent systems: log the input, the retrieved context, the generated output, and provide a human review interface.

For multi-agent systems, the framework's principles still apply, but the implementation is less clear:

• Explainability now requires explaining not just the final output, but the intent classification, the agent selection logic, and the synthesis process. A clinician reviewing a patient-facing recommendation needs to know which agents contributed, what each recommended, and how conflicts were resolved.
• Human oversight must operate at multiple levels: oversight of the intent router (is it sending queries to the right agents?), oversight of individual agents (are their outputs clinically sound?), and oversight of the synthesis step (is it faithfully representing agent outputs or introducing new content?).
• Auditability demands agent-level logs. If a patient receives incorrect guidance, the audit trail must show which agent produced the error, what context it retrieved, and whether the synthesis step amplified or mitigated the mistake.

The WHO's guidance on AI for health [2] adds requirements for accountability, safety monitoring, and risk management. It specifies that "AI systems should be designed to allow traceability of decisions" and that "mechanisms should be in place to identify and address errors." For multi-agent systems, this means:

• Traceability requires versioning not just the model weights, but the prompt for each agent, the retrieval pipeline configuration, the intent classification logic, and the synthesis rules.
• Error identification must distinguish between agent-level errors (one agent produces a bad output) and system-level errors (the synthesis step combines good agent outputs into a bad recommendation).
• Risk management must account for cascading failures: an intent routing error sends a query to the wrong agent, which produces plausible but irrelevant output, which the synthesis step incorporates without flagging the mismatch.

Neither framework provides a ready-made checklist for multi-agent LLM validation. We propose one below.

A five-checkpoint validation protocol for multi-agent clinical LLMs

When evaluating a multi-agent LLM system for clinical deployment, Singapore hospitals should require vendors (or internal teams) to demonstrate the following:

1. Intent classification accuracy with clinical edge cases. Test the intent router on queries that span multiple clinical domains ("My blood pressure is high and I'm planning surgery—what should I do?") or that are ambiguous ("I feel tired all the time"). Measure not just top-1 accuracy, but the rate of multi-intent queries and how the system handles them. Require a confusion matrix showing which intents are most often conflated.

2. Agent output consistency under retrieval variation. For each agent, test whether small changes in the retrieved context produce large changes in the output. This is the agent-level equivalent of RAG robustness testing. If the lifestyle guidance agent recommends different exercise regimens when the patient's age is 58 versus 59, the agent is overfitting to noise.

3. Synthesis logic transparency and conflict resolution. Require documentation of how the synthesis step works. If it is rule-based, provide the rules. If it is LLM-based, provide the prompt and examples of how it handles conflicting agent outputs. Test cases where agents disagree (e.g., the clinical reasoning agent says "continue current medication," the lifestyle agent says "consider non-pharmacological interventions first") and verify that the synthesis step flags the conflict rather than silently choosing one.

4. Failure mode mapping across agents. For each agent, enumerate the failure modes (hallucination, retrieval failure, prompt injection, out-of-scope query) and test whether the system detects them. Then test cross-agent failure modes: does an intent routing error compound into a synthesis error? Does one agent's hallucination contaminate the final output even if other agents are correct?

5. Agent-level audit trails in production. Require that the production system log, for every query: which agents were invoked, what context each retrieved, what each recommended, and how the synthesis step combined them. These logs must be queryable for clinical review and retrospective audit. If the system cannot produce this data, it is not governable.

This protocol is not exhaustive, but it provides a starting point. We have used versions of it to evaluate multi-agent proposals for patient triage and chronic disease management in Singapore health systems. In both cases, the protocol surfaced issues that end-to-end accuracy testing missed: intent routers that failed on multi-domain queries, synthesis steps that silently dropped agent outputs, and logging systems that did not capture agent-level data.

Why this matters in Singapore

Singapore's healthcare AI ecosystem is moving quickly. The Ministry of Health has signaled support for AI-enabled care coordination and chronic disease management. Health systems are piloting LLM-based tools for patient communication, care summaries, and clinical decision support. Multi-agent architectures are attractive because they promise modularity: you can swap out the lifestyle guidance agent without retraining the clinical reasoning agent, or add a new agent for medication reconciliation without touching the others.

But modularity introduces governance complexity. A single-agent system has one model to validate, one prompt to version, one retrieval pipeline to audit. A multi-agent system has n agents, each with its own validation surface, plus the intent router and synthesis logic. If Singapore hospitals adopt multi-agent LLMs without governance scaffolding, we risk deploying systems that are individually sound but collectively ungovernable.

The stakes are higher for patient-facing systems. The preprint describes a system for health checkup interpretation [4]—a use case where patients receive personalized guidance without clinician review. If the system misroutes a query, produces conflicting agent outputs, or synthesizes them incorrectly, the patient may act on bad advice before a clinician sees the error. Singapore's regulatory environment (PDPA for data protection, HSA for medical devices) does not yet specify requirements for multi-agent clinical AI, but the principles are clear: traceability, explainability, and accountability. Multi-agent systems must meet those principles at the agent level, not just the system level.

What to do next

If you are evaluating a multi-agent LLM system for clinical deployment in Singapore:

• Request agent-level documentation: prompt templates, retrieval pipeline configurations, and synthesis logic for each agent. If the vendor cannot provide this, the system is not ready for clinical use.
• Test intent routing on clinical edge cases: multi-domain queries, ambiguous symptoms, and out-of-scope requests. Measure not just accuracy, but the rate of routing failures and how the system handles them.
• Require agent-level logging in production: every query should generate a log entry showing which agents were invoked, what each retrieved and recommended, and how outputs were synthesized. Make these logs queryable for clinical review.
• Map failure modes across agents: enumerate how each agent can fail, then test whether failures cascade (intent routing error → wrong agent → bad synthesis). Verify that the system detects and flags cross-agent failures.
• Align with existing governance frameworks: use Singapore's Model AI Governance Framework [1] and WHO guidance [2] as a baseline, then extend them to cover intent routing, agent handoffs, and synthesis logic. Document how your validation protocol addresses each principle.

If you are building a multi-agent clinical LLM, design for governance from the start. Version every agent's prompt and retrieval pipeline. Log agent-level outputs before synthesis. Build interfaces for clinicians to review agent reasoning, not just final outputs. And test not just end-to-end accuracy, but the intermediate steps: intent classification, agent consistency, and synthesis transparency.

For hospitals and health systems looking to navigate these governance challenges, InsytAI services include multi-agent LLM evaluation, agent-level validation protocols, and governance framework alignment for Singapore healthcare AI deployments. If you are piloting a multi-agent system and need a governance audit, start a project with us.

FAQ

What is a multi-agent LLM system?

A multi-agent LLM system uses multiple specialized language models (or prompt configurations) to handle different aspects of a task. For example, one agent might interpret lab results, another might provide lifestyle guidance, and a third might suggest follow-up care. The system routes user queries to the appropriate agents, executes them (often in parallel), and synthesizes their outputs into a single response. This differs from single-agent systems, where one model handles the entire task.

Why are multi-agent systems harder to govern than single-agent systems?

Multi-agent systems introduce three new governance surfaces: (1) intent routing, where the system must classify the user's query and send it to the right agent; (2) agent handoffs, where the system must decide which agents to invoke and how to sequence or parallelize them; and (3) output synthesis, where the system must combine agent outputs into a coherent response. Each surface has its own failure modes, and failures can cascade across agents. Existing governance frameworks focus on single-model systems and do not specify how to audit these intermediate steps.

Does Singapore have specific regulations for multi-agent clinical AI?

Not yet. Singapore's Model AI Governance Framework [1] provides principles (transparency, explainability, human oversight) that apply to all AI systems, including multi-agent architectures. The Health Sciences Authority (HSA) regulates AI as medical devices when they meet Software as a Medical Device (SaMD) criteria, but does not have multi-agent-specific guidance. The Personal Data Protection Act (PDPA) governs data use but does not address multi-agent architectures. Hospitals must interpret existing frameworks and apply them to multi-agent systems, which is why we recommend the five-checkpoint validation protocol above.

How do I audit a multi-agent LLM system in production?

Require agent-level logging: for every query, the system should record which agents were invoked, what context each retrieved, what each recommended, and how the synthesis step combined them. These logs should be queryable so clinicians can review agent reasoning when a patient reports an issue or when you conduct retrospective audits. You should also monitor intent classification accuracy (are queries being routed to the right agents?), agent output consistency (are agents producing stable outputs for similar queries?), and synthesis fidelity (is the final output faithfully representing agent recommendations?).

Sources

[1] Personal Data Protection Commission Singapore. (2020). Model AI Governance Framework. https://www.pdpc.gov.sg/help-and-resources/2020/01/model-ai-governance-framework

[2] World Health Organization. (2021). Ethics and governance of artificial intelligence for health. https://www.who.int/publications/i/item/9789240029200

[3] World Health Organization. Ethics and governance of artificial intelligence for health. https://www.who.int/publications/i/item/9789240029200

[4] arXiv preprint. (2026). A Multi-Agent LLM Framework for Personalized Health Checkup Interpretation and Guidance. https://arxiv.org/abs/2610.01451v1

[5] PLOS Digital Health. (2026). Artificial intelligence for evaluation of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001763

[6] PLOS Digital Health. (2026). STREAM: A data-driven framework for physiological state monitoring in ICU patients. https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001753

[7] LangChain Blog. (2026). Scaling Agents in Healthcare & Life Sciences: Lessons from Madrigal Pharmaceuticals, Abridge, and Vizient. https://www.langchain.com/blog/scaling-agents-in-healthcare-life-sciences-lessons-from-madrigal-pharmaceuticals-abridge-and-vizient